Dr. Ramji Lal is a distinguished analytical pharmaceutical scientist with over 20 years of experience in the pharmaceutical industry following the completion of his Ph.D. He is the General Manager of Analytical Development at Mankind Research Centre, a unit of Mankind Pharma Ltd, in Manesar, Gurgaon, India.

Dr. Lal's expertise spans various analytical techniques and methodologies crucial to pharmaceutical research and development. His areas of specialization include separation, purification, identification, and quantification of organic compounds, as well as physicochemical characterization of drug substances and products. He has extensive experience in complex injectables, ophthalmic formulations, and APIs.

Educational Background:

Ph.D. in Organo-electrochemistry from Jiwaji University, Gwalior, India (2006) M.Sc. in Organic Chemistry from Jiwaji University, Gwalior, India (2002) B.Sc. from Jiwaji University, Gwalior, India (2000) Professional Experience:

General Manager, Analytical Development, Mankind Research Centre (2017-Present) Manager, Analytical Development, DSM-Sinochem Pharma Pvt Ltd (2013-2017) Deputy Manager, Analytical Research, Mylan Laboratories Ltd (2009-2013) Senior Research Officer, Analytical Research, Glenmark Generics Ltd (2005-2009) Dr. Lal's research interests include polymorphic studies, solid-state characterization, impurity profiling, and method development for various pharmaceutical compounds. He has expertise in using advanced analytical techniques such as PXRD, TGA, DSC, SEM, Dynamic Vapor Sorption (DVS), NMR, and various spectroscopic methods.

Throughout his career, Dr. Lal has demonstrated strong leadership skills, managed teams of scientists and overseeing multiple complex projects simultaneously. He has been instrumental in implementing Quality by Design (QbD) principles in analytical development and has extensive experience in regulatory affairs, including preparing documentation for dossier submissions and addressing regulatory queries.

Dr. Lal is an inventor on a granted US patent (US 8,623,844 B2) related to Fosaprepitant Dimeglumine. He has also authored several peer-reviewed publications in reputable scientific journals, showcasing his contributions to the field of pharmaceutical analysis and organic synthesis.

Professional Development: Dr. Lal actively participates in workshops and seminars to stay abreast of the latest developments in his field. He has attended international meetings on solid-state chemistry in pharmaceutical science and has received specialized training in particle size and shape determination techniques.

For a more comprehensive view of Dr. Ramji Lal's professional background and research outputs, please visit his profiles on:

LinkedIn: [LinkedIn profile URL] Google Scholar: [Google Scholar profile URL] ORCID: [ORCID profile URL] Mankind Research Centre: [Institutional website URL]

Dr. Lal's commitment to advancing pharmaceutical analytical science, combined with his extensive industry experience and technical expertise, makes him a valuable asset to the scientific community and the pharmaceutical industry.